Unravelling the enhanced rifampicin photocatalytic degradation over green-synthesized SrO 2 @SnIn 4 S 8 p-n heterojunction: Pathway, toxicity evaluation and mechanistic insights

In recent years, the discharge of pharmaceutical drugs into aquatic ecosystems has become a growing concern, posing a significant threat to aquatic life. In response to this environmental challenge, advanced oxidation processes have gained prominence in wastewater treatment due to their efficacy in eliminating pharmaceutical pollutants and their potential for reusability. In this study, we have fabricated SnIn S coupled SrO nano-heterojunction (NH) using a greener co-precipitation approach using leaf extract derived from Acaphyla wilkesiana. The resulting NH exhibited exceptional photocatalytic activity against rifampicin (RIF), achieving a remarkable 97.4% degradation under visible light, surpassing the performance of its individual components. The morphological characteristics of the NH were thoroughly analyzed through SEM, TEM, XRD, and XPS techniques, while EIS, DRS, and BET techniques provided valuable insights into its photocatalytic and optical properties. Furthermore, radical scavenging assays and ESR analysis identified hydroxyl radicals (•OH) and superoxide radicals (O ) were the species contributing to the visible light-driven photocatalytic degradation. The study also elucidated the potential degradation pathways and intermediates of RIF through GC-MS analysis. Additionally, the toxicity of the produced intermediates was assessed using the ECOSAR model. The findings have significant implications for the treatment of pharmaceutical pollutants and underscore the importance of eco-friendly synthesis methods in addressing environmental challenges.